 CELEBRATION, Fla., June 03, 2021 GLOBE NEWSWIRE -- KemPharm, Inc. NASDAQ: KMPH, a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that Travis C. Mickle, Ph.D., President and Chief Executive Officer of KemPharm, will participate in a panel discussion on the regulatory environment during the COVID-19 pandemic at the Consero Global IP Management and IP Life Sciences Virtual Forum taking place June 7-8, 2021. 